CorMedix Inc. (CRMD) board approves multi-year $75M stock buyback
I'm PortAI, I can summarize articles.
CorMedix Inc. (NASDAQ:CRMD) has announced a share repurchase program approved by its board, allowing for up to $75 million in common stock buybacks. This program will be active until December 31, 2027, reflecting the company's confidence in its long-term prospects.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments